Published in Blood on May 15, 2001
Mechanism for fetal hemoglobin induction by histone deacetylase inhibitors involves gamma-globin activation by CREB1 and ATF-2. Blood (2006) 1.27
Short-chain fatty acid derivatives induce fetal globin expression and erythropoiesis in vivo. Blood (2002) 1.26
Lactic acid bacteria contribution to gut microbiota complexity: lights and shadows. Front Cell Infect Microbiol (2012) 1.18
Short-chain fatty acids induce gamma-globin gene expression by displacement of a HDAC3-NCoR repressor complex. Blood (2006) 1.15
Enhancement of growth and survival and alterations in Bcl-family proteins in beta-thalassemic erythroid progenitors by novel short-chain fatty acid derivatives. Blood Cells Mol Dis (2005) 1.03
Fetal globin induction--can it cure beta thalassemia? Hematology Am Soc Hematol Educ Program (2005) 0.97
Induction of fetal globin in beta-thalassemia: Cellular obstacles and molecular progress. Ann N Y Acad Sci (2005) 0.96
Fetal globin gene inducers: novel agents and new potential. Ann N Y Acad Sci (2010) 0.95
Erythroid Kruppel-like factor (EKLF) is recruited to the gamma-globin gene promoter as a co-activator and is required for gamma-globin gene induction by short-chain fatty acid derivatives. Eur J Haematol (2009) 0.93
Hydroxyurea responsiveness in β-thalassemic patients is determined by the stress response adaptation of erythroid progenitors and their differentiation propensity. Haematologica (2012) 0.91
Histone deacetylase 9 activates gamma-globin gene expression in primary erythroid cells. J Biol Chem (2010) 0.90
Signalling cross-talk between hepatocyte nuclear factor 4alpha and growth-hormone-activated STAT5b. Biochem J (2006) 0.90
Butyrate histone deacetylase inhibitors. Biores Open Access (2012) 0.90
Regulation of γ-globin gene expression involves signaling through the p38 MAPK/CREB1 pathway. Blood Cells Mol Dis (2011) 0.88
Epigenetic regulation of fetal globin gene expression in adult erythroid cells. Transl Res (2014) 0.87
Identification of novel small-molecule inducers of fetal hemoglobin using pharmacophore and 'PSEUDO' receptor models. Chem Biol Drug Des (2006) 0.86
Novel therapeutic candidates, identified by molecular modeling, induce γ-globin gene expression in vivo. Blood Cells Mol Dis (2011) 0.85
Short-chain fatty acid-mediated effects on erythropoiesis in primary definitive erythroid cells. Blood (2009) 0.83
A phase 1/2 trial of HQK-1001, an oral fetal globin inducer, in sickle cell disease. Am J Hematol (2012) 0.83
Evaluation of safety and pharmacokinetics of sodium 2,2 dimethylbutyrate, a novel short chain fatty acid derivative, in a phase 1, double-blind, placebo-controlled, single-dose, and repeat-dose studies in healthy volunteers. J Clin Pharmacol (2011) 0.81
Liquid chromatography-mass spectrometric assay for quantitation of the short-chain fatty acid, 2,2-dimethylbutyrate (NSC 741804), in rat plasma. J Chromatogr B Analyt Technol Biomed Life Sci (2007) 0.81
Novel Inducers of Fetal Globin Identified through High Throughput Screening (HTS) Are Active In Vivo in Anemic Baboons and Transgenic Mice. PLoS One (2015) 0.78
Cell signaling pathways involved in drug-mediated fetal hemoglobin induction: Strategies to treat sickle cell disease. Exp Biol Med (Maywood) (2015) 0.76
Evaluation of Signaling Pathways Involved in γ-Globin Gene Induction Using Fetal Hemoglobin Inducer Drugs. Int J Hematol Oncol Stem Cell Res (2013) 0.75
Therapeutic fetal-globin inducers reduce transcriptional repression in hemoglobinopathy erythroid progenitors through distinct mechanisms. Blood Cells Mol Dis (2015) 0.75
WAF1, a potential mediator of p53 tumor suppression. Cell (1993) 38.72
The retinoblastoma protein and cell cycle control. Cell (1995) 20.21
Oncogenes and signal transduction. Cell (1991) 14.84
Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev (1995) 13.66
p53: puzzle and paradigm. Genes Dev (1996) 13.16
G1 events and regulation of cell proliferation. Science (1989) 9.73
Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J Biol Chem (1990) 9.21
Mammalian G1 cyclins. Cell (1993) 9.04
STATs: signal transducers and activators of transcription. Cell (1996) 6.10
Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell (1998) 5.92
The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. Gene Expr (1996) 4.62
Demonstration of permanent factor-dependent multipotential (erythroid/neutrophil/basophil) hematopoietic progenitor cell lines. Proc Natl Acad Sci U S A (1983) 3.76
Identification and characterization of a constitutively active STAT5 mutant that promotes cell proliferation. Mol Cell Biol (1998) 3.23
STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells. EMBO J (1999) 3.14
Resolution of histones by polyacrylamide gel electrophoresis in presence of nonionic detergents. Methods Cell Biol (1978) 3.00
A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders. N Engl J Med (1993) 2.76
Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease. Blood (1999) 2.66
Cytokine-dependent granulocytic differentiation. Regulation of proliferative and differentiative responses in a murine progenitor cell line. J Immunol (1987) 2.54
The rapid inactivation of nuclear tyrosine phosphorylated Stat1 depends upon a protein tyrosine phosphatase. EMBO J (1996) 2.50
Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line. J Biol Chem (1997) 2.10
Extended therapy with intravenous arginine butyrate in patients with beta-hemoglobinopathies. N Engl J Med (1995) 2.05
Suppression of interleukin-3-induced gene expression by a C-terminal truncated Stat5: role of Stat5 in proliferation. EMBO J (1996) 2.02
Restriction point control of cell growth by a labile protein: evidence for increased stability in transformed cells. Proc Natl Acad Sci U S A (1982) 1.93
On the biological role of histone acetylation. Biochem J (1990) 1.92
Tyrosine 343 in the erythropoietin receptor positively regulates erythropoietin-induced cell proliferation and Stat5 activation. EMBO J (1995) 1.87
Different accessibilities in chromatin to histone acetylase. J Biol Chem (1979) 1.79
Induction of fetal hemoglobin production in subjects with sickle cell anemia by oral sodium phenylbutyrate. Blood (1994) 1.56
Apoptosis in colorectal tumour cells: induction by the short chain fatty acids butyrate, propionate and acetate and by the bile salt deoxycholate. Int J Cancer (1995) 1.54
Concentration-dependent effects of sodium butyrate in Chinese hamster cells: cell-cycle progression, inner-histone acetylation, histone H1 dephosphorylation, and induction of an H1-like protein. Biochemistry (1980) 1.47
STAT5 activation contributes to growth and viability in Bcr/Abl-transformed cells. Blood (2000) 1.44
The retinoblastoma protein: a master regulator of cell cycle, differentiation and apoptosis. Eur J Biochem (1997) 1.41
Prevalent deficiency in tumor cells of cycloheximide-induced cycle arrest. Proc Natl Acad Sci U S A (1980) 1.40
Butyrate-induced G1 arrest results from p21-independent disruption of retinoblastoma protein-mediated signals. Cell Growth Differ (1998) 1.28
Alterations in protein-DNA interactions in the gamma-globin gene promoter in response to butyrate therapy. Blood (1998) 1.24
Sodium butyrate enhances fetal globin gene expression in erythroid progenitors of patients with Hb SS and beta thalassemia. Blood (1989) 1.23
Butyrate infusions in the ovine fetus delay the biologic clock for globin gene switching. Proc Natl Acad Sci U S A (1988) 1.22
Apoptotic death in adenocarcinoma cell lines induced by butyrate and other histone deacetylase inhibitors. Biochem Pharmacol (1997) 1.20
Interleukin-3-induced activation of the JAK/STAT pathway is prolonged by proteasome inhibitors. Blood (1998) 1.14
Requirement of an E1A-sensitive coactivator for long-range transactivation by the beta-globin locus control region. J Biol Chem (1999) 1.13
Delay in the fetal globin switch in infants of diabetic mothers. N Engl J Med (1985) 1.12
Multiple functions of dynamic histone acetylation. J Cell Biochem (1994) 1.10
alpha-Amino butyric acid cannot reactivate the silenced gamma gene of the beta locus YAC transgenic mouse. Blood (1994) 1.08
Protein p53 and inducer-mediated erythroleukemia cell commitment to terminal cell division. Proc Natl Acad Sci U S A (1983) 1.08
Myb-induced transformation. Crit Rev Oncog (1996) 1.06
Stimulation of fetal hemoglobin production by short chain fatty acids. Blood (1995) 1.03
Cancer cell sensitization to fas-mediated apoptosis by sodium butyrate. Cell Death Differ (1998) 1.02
The role of butyrate in human colonic epithelial cells: an energy source or inducer of differentiation and apoptosis? Proc Nutr Soc (1996) 1.02
Effect of sodium butyrate on induction of cellular and viral DNA syntheses in polyoma virus-infected mouse kidney cells. J Virol (1981) 0.98
Physical and functional interactions between Stat5 and the tyrosine-phosphorylated receptors for erythropoietin and interleukin-3. Blood (1996) 0.97
Sodium butyrate induces apoptosis and accumulation of ubiquitinated proteins in human breast carcinoma cells. Cell Death Differ (1998) 0.95
Novel in vitro assay for the detection of pharmacologic inducers of fetal hemoglobin. Blood (2000) 0.94
The effects of sodium butyrate on transcription are mediated through activation of a protein phosphatase. J Biol Chem (1997) 0.93
Butyrate induces selective transcriptional activation of a hypomethylated embryonic globin gene in adult erythroid cells. Blood (1988) 0.92
Butyrate blocks the accumulation of CDC2 mRNA in late G1 phase but inhibits both the early and late G1 progression in chemically transformed mouse fibroblasts BP-A31. J Cell Physiol (1990) 0.92
Induction of fetal hemoglobin in sickle cell disease. Blood (1999) 0.90
Butyrate inhibits mouse fibroblasts at a control point in the G1 phase. J Cell Biochem (1983) 0.89
Characterization of the Stat5 protease. J Biol Chem (1999) 0.88
Butyrate induced apoptosis in lymphoid cells preceded by transient over-expression of HSP70 mRNA. Biochem Biophys Res Commun (1994) 0.85
Cellular and molecular effects of a pulse butyrate regimen and new inducers of globin gene expression and hematopoiesis. Ann N Y Acad Sci (1998) 0.85
Erythroid progenitor proliferation is stimulated by phenoxyacetic and phenylalkyl acids. Blood Cells Mol Dis (1996) 0.85
Cells inhibited by n-butyrate support adenovirus replication. Virology (1980) 0.84
Abrogation of IL-3 requirements and stimulation of hematopoietic cell proliferation in vitro and in vivo by carboxylic acids. Blood Cells Mol Dis (1997) 0.83
Sodium butyrate in combination with insulin or dexamethasone can terminally differentiate actively proliferating Swiss 3T3 cells into adipocytes. J Biol Chem (1990) 0.83
Apoptosis induced by sodium butyrate treatment increases immunogenicity of a rat colon tumor cell line. Apoptosis (1997) 0.82
Butyrate attenuates BCLX(L) expression in human fibroblasts and acts in synergy with ionizing radiation to induce apoptosis. Radiat Res (1998) 0.82
Insulin-like growth factor-I augments erythropoietin-induced proliferation through enhanced tyrosine phosphorylation of STAT5. J Biol Chem (1998) 0.82
Butyric acid and pivaloyloxymethyl butyrate, AN-9, a novel butyric acid derivative, induce apoptosis in HL-60 cells. J Cancer Res Clin Oncol (1997) 0.81
Vincristine- and cisplatin-induced apoptosis in human retinoblastoma. Potentiation by sodium butyrate. Eur J Cancer (1998) 0.81
Differentiation inducers modulate cytokine signaling pathways in a murine erythroleukemia cell line. Cancer Res (1998) 0.81
Mitogen-activated protein kinases enhance long-range activation by the beta-globin locus control region. Proc Natl Acad Sci U S A (1998) 0.81
Effect of butyrate and corticosteroids on retinoblastoma in vitro and in vivo. Invest Ophthalmol Vis Sci (1991) 0.81
TGF-alpha and TGF-beta expression during sodium-N-butyrate-induced differentiation of human keratinocytes: evidence for subpopulation-specific up-regulation of TGF-beta mRNA in suprabasal cells. Exp Cell Res (1990) 0.80
Selective induction of apoptosis in myeloid leukemic cell lines by monoacetone glucose-3 butyrate. Biochem Biophys Res Commun (1994) 0.80
The extent of histone acetylation induced by butyrate and the turnover of acetyl groups depend on the nature of the cell line. Eur J Biochem (1981) 0.79
Murine A-myb gene encodes a transcription factor, which cooperates with Ets-2 and exhibits distinctive biochemical and biological activities from c-myb. J Biol Chem (1997) 0.79
Butyrate reversibly arrests the proliferation of normal and Rous sarcoma virus-infected chicken heart mesenchymal cells. Life Sci (1984) 0.79
Sodium butyrate inhibits the synthesis of the transformation related protein p 53 in 3T6 mouse fibroblasts. FEBS Lett (1984) 0.78
Butyrate-stable monosaccharide derivatives induce maturation and apoptosis in human acute myeloid leukaemia cells. Br J Haematol (1998) 0.76
A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res (1991) 13.54
Highly parallel SNP genotyping. Cold Spring Harb Symp Quant Biol (2003) 9.10
Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target. Proc Natl Acad Sci U S A (2006) 6.33
Identification of critical staphylococcal genes using conditional phenotypes generated by antisense RNA. Science (2001) 5.40
Characterization and mapping of RNase T1-resistant oligonucleotides derived from the genomes of Akv and MCF murine leukemia viruses. Proc Natl Acad Sci U S A (1978) 5.25
Use of oral corticosteroids and risk of fractures. J Bone Miner Res (2000) 4.75
A three-hybrid system to detect RNA-protein interactions in vivo. Proc Natl Acad Sci U S A (1996) 4.44
Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform. Neuron (1999) 3.49
Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. J Clin Invest (1991) 3.18
Oxygen tension regulates the expression of the platelet-derived growth factor-B chain gene in human endothelial cells. J Clin Invest (1990) 2.94
Developmentally dynamic histone acetylation pattern of a tissue-specific chromatin domain. Proc Natl Acad Sci U S A (2000) 2.83
A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders. N Engl J Med (1993) 2.76
Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor. Nat Med (1999) 2.74
Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease. Blood (1999) 2.66
Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Ann Rheum Dis (2008) 2.55
RNase T1-resistant oligonucleotides of B-tropic murine leukemia virus from BALB/c and five of its NB-tropic derivatives. J Virol (1977) 2.51
Malignant transformation in a nontumorigenic human prostatic epithelial cell line. Cancer Res (2001) 2.50
Distinct mechanisms control RNA polymerase II recruitment to a tissue-specific locus control region and a downstream promoter. Mol Cell (2001) 2.32
Direct interaction of NF-E2 with hypersensitive site 2 of the beta-globin locus control region in living cells. Blood (2000) 2.31
You bet-cha: a novel family of transcriptional regulators. Front Biosci (2001) 2.20
RNase T1-resistant oligonucleotides of Akv-1 and Akv-2 type C viruses of AKR mice. J Virol (1977) 2.17
Broadband observations of the naked-eye gamma-ray burst GRB 080319B. Nature (2008) 2.16
Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia. J Clin Invest (1993) 2.14
Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology (Oxford) (2000) 2.13
RING3 kinase transactivates promoters of cell cycle regulatory genes through E2F. Cell Growth Differ (2000) 2.13
Relativistic jet activity from the tidal disruption of a star by a massive black hole. Nature (2011) 2.12
Nucleotide sequence of a major messenger RNA for a 21 kilodalton polypeptide that is under translational control in mouse tumor cells. Nucleic Acids Res (1988) 2.08
Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes. Diabetes Obes Metab (2006) 2.05
Fold and function predictions for Mycoplasma genitalium proteins. Fold Des (1998) 2.02
Severe diffuse non-scarring hair loss in systemic lupus erythematosus - clinical and histopathological analysis of four cases. J Eur Acad Dermatol Venereol (2011) 1.99
Use of oral corticosteroids in the United Kingdom. QJM (2000) 1.95
Diffusion tensor imaging and cognitive function in older adults with no dementia. Neurology (2011) 1.89
Histone acetylation beyond promoters: long-range acetylation patterns in the chromatin world. Bioessays (2001) 1.88
Relative contribution of the leukocyte molecules Mo1, LFA-1, and p150,95 (LeuM5) in adhesion of granulocytes and monocytes to vascular endothelium is tissue- and stimulus-specific. J Cell Physiol (1988) 1.88
GeneKeyDB: a lightweight, gene-centric, relational database to support data mining environments. BMC Bioinformatics (2005) 1.83
SIRT1 induces EMT by cooperating with EMT transcription factors and enhances prostate cancer cell migration and metastasis. Oncogene (2012) 1.70
The use of a large pharmacoepidemiological database to study exposure to oral corticosteroids and risk of fractures: validation of study population and results. Pharmacoepidemiol Drug Saf (2000) 1.70
Do satellites detect trends in surface solar radiation? Science (2005) 1.69
Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study. Diabetologia (2010) 1.68
Scalable templated growth of graphene nanoribbons on SiC. Nat Nanotechnol (2010) 1.66
Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Arthritis Rheum (2008) 1.66
The expanding burden of cardiometabolic risk in China: the China Health and Nutrition Survey. Obes Rev (2012) 1.66
Novel peroxisome proliferator-activated receptor (PPAR) gamma and PPARdelta ligands produce distinct biological effects. J Biol Chem (1999) 1.65
Diverse peroxisome proliferator-activated receptors bind to the peroxisome proliferator-responsive elements of the rat hydratase/dehydrogenase and fatty acyl-CoA oxidase genes but differentially induce expression. Proc Natl Acad Sci U S A (1993) 1.65
An MRI-based parcellation method for the temporal lobe. Neuroimage (2000) 1.62
An oncogenic role of miR-142-3p in human T-cell acute lymphoblastic leukemia (T-ALL) by targeting glucocorticoid receptor-α and cAMP/PKA pathways. Leukemia (2011) 1.61
Retracted Requirement for chromatin-remodeling complex in novel tumor suppressor HIC1-mediated transcriptional repression and growth control. Oncogene (2008) 1.59
Nucleotide sequence for a major messenger RNA for a 40 kilodalton polypeptide that is under translational control in mouse tumor cells. Nucleic Acids Res (1988) 1.57
Urinary ovarian and gonadotropin hormone levels in premenopausal women with low bone mass. J Bone Miner Res (1998) 1.57
Adhesion of T lymphocytes to human endothelial cells is regulated by the LFA-1 membrane molecule. J Cell Physiol (1986) 1.57
Safety, efficacy and biological predictors of response to sequential azacitidine and lenalidomide for elderly patients with acute myeloid leukemia. Leukemia (2011) 1.55
Control of sigma factor activity during Bacillus subtilis sporulation. Mol Microbiol (1999) 1.54
Transcriptional control of erythropoiesis: emerging mechanisms and principles. Oncogene (2007) 1.52
Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes. J Immunol (1985) 1.52
Oncogenic ras induces an inhibitor of double-stranded RNA-dependent eukaryotic initiation factor 2 alpha-kinase activation. J Biol Chem (1992) 1.50
Protein tyrosine kinase activation is required for lipopolysaccharide induction of cytokines in human blood monocytes. J Immunol (1993) 1.50
Functional insights from structural predictions: analysis of the Escherichia coli genome. Protein Sci (1999) 1.49
Elevated serum antibodies against insulin-like growth factor-binding protein-2 allow detecting early-stage cancers: evidences from glioma and colorectal carcinoma studies. Ann Oncol (2012) 1.49
T1 oligonucleotide maps of N-, B-, and B leads to NB-tropic murine leukemia viruses derived from BALB/c. J Virol (1978) 1.47
Clinical trial: sodium phosphate tablets are preferred and better tolerated by patients compared to polyethylene glycol solution plus bisacodyl tablets for bowel preparation. Aliment Pharmacol Ther (2007) 1.47
Dementia with Lewy bodies and Alzheimer disease: neurodegenerative patterns characterized by DTI. Neurology (2010) 1.45
Minimal residual disease quantification using consensus primers and high-throughput IGH sequencing predicts post-transplant relapse in chronic lymphocytic leukemia. Leukemia (2013) 1.45
Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis: one-year follow-up in five patients. Blood (1996) 1.42
Insulin receptor-related receptor messenger ribonucleic acid is focally expressed in sympathetic and sensory neurons and renal distal tubule cells. Endocrinology (1993) 1.42
Functional antagonism between CCAAT/Enhancer binding protein-alpha and peroxisome proliferator-activated receptor-gamma on the leptin promoter. J Biol Chem (1997) 1.42
A survey of men who have sex with men: mainland China. Am J Public Health (2000) 1.41
A human prostatic epithelial model of hormonal carcinogenesis. Cancer Res (2001) 1.40
Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis: the serum cytokine profile and peripheral cell population. Clin Exp Immunol (2009) 1.40
Distinct FTDP-17 missense mutations in tau produce tau aggregates and other pathological phenotypes in transfected CHO cells. Mol Biol Cell (2000) 1.39
An unexpectedly rapid decline in the X-ray afterglow emission of long gamma-ray bursts. Nature (2005) 1.39
Large T1 oligonucleotides of Moloney leukemia virus missing in an env gene recombinant, HIX, are present on an intracellular 21S Moloney viral RNA species. Proc Natl Acad Sci U S A (1978) 1.39
A multiparameter analysis of sickle erythrocytes in patients undergoing hydroxyurea therapy. Blood (1996) 1.39
Age-related changes in climbing behavior and neural circuit physiology in Drosophila. Dev Neurobiol (2007) 1.37
Interleukin 1 induces cultured human endothelial cell production of granulocyte-macrophage colony-stimulating factor. J Clin Invest (1987) 1.36
Requirement of heavy neurofilament subunit in the development of axons with large calibers. J Cell Biol (1998) 1.32
A short gamma-ray burst apparently associated with an elliptical galaxy at redshift z = 0.225. Nature (2005) 1.32
The association of GRB 060218 with a supernova and the evolution of the shock wave. Nature (2006) 1.32
Downregulation of microRNA-126 in endothelial progenitor cells from diabetes patients, impairs their functional properties, via target gene Spred-1. J Mol Cell Cardiol (2012) 1.30
Fold prediction by a hierarchy of sequence, threading, and modeling methods. Protein Sci (1998) 1.29
Butyrate-induced G1 arrest results from p21-independent disruption of retinoblastoma protein-mediated signals. Cell Growth Differ (1998) 1.28
A novel all helix fold of the AP180 amino-terminal domain for phosphoinositide binding and clathrin assembly in synaptic vesicle endocytosis. Cell (2001) 1.28
Age-dependent induction of congophilic neurofibrillary tau inclusions in tau transgenic mice. Am J Pathol (2001) 1.28
Loss of Nkx3.1 leads to the activation of discrete downstream target genes during prostate tumorigenesis. Oncogene (2009) 1.28
Long-term effects of exenatide therapy over 82 weeks on glycaemic control and weight in over-weight metformin-treated patients with type 2 diabetes mellitus. Diabetes Obes Metab (2006) 1.27
A panel of monoclonal antibodies for the type I insulin-like growth factor receptor. Epitope mapping, effects on ligand binding, and biological activity. J Biol Chem (1992) 1.27
Alpha and beta subunits of the LFA-1 membrane molecule are involved in human monocyte-endothelial cell adhesion. J Cell Physiol (1987) 1.26
Evidence that the 90-kilodalton heat shock protein is associated with tubulin-containing complexes in L cell cytosol and in intact PtK cells. Mol Endocrinol (1988) 1.26
Direct evidence that the glucocorticoid receptor binds to hsp90 at or near the termination of receptor translation in vitro. J Biol Chem (1989) 1.25
RNase T1-resistant oligonucleotides of an N- and a B-tropic murine leukemia virus of BALB/c: evidence for recombination between these viruses. J Virol (1977) 1.25
The emergence of cardiometabolic disease risk in Chinese children and adults: consequences of changes in diet, physical activity and obesity. Obes Rev (2014) 1.24
Platelet-derived growth factor signal transduction through the interferon-inducible kinase PKR. Immediate early gene induction. J Biol Chem (1995) 1.24
In vivo detection of amyloid plaques in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A (2000) 1.24
Research design and statistical methods in Chinese medical journals. JAMA (1998) 1.24
Implication of dysregulation of the canonical wingless-type MMTV integration site (WNT) pathway in diabetic nephropathy. Diabetologia (2011) 1.24
Alterations in protein-DNA interactions in the gamma-globin gene promoter in response to butyrate therapy. Blood (1998) 1.24
Sodium butyrate enhances fetal globin gene expression in erythroid progenitors of patients with Hb SS and beta thalassemia. Blood (1989) 1.23
Butyrate infusions in the ovine fetus delay the biologic clock for globin gene switching. Proc Natl Acad Sci U S A (1988) 1.22